ECI Pharmaceuticals, LLC – FDA 483, Feb 27, 2015
ECR Pharmaceuticals LLC, a prescription oral drug manufacturer in Ft Lauderdale, FL, was cited for significant deficiencies in its quality system during an FDA inspection. Observations included inadequate production and process controls, unapproved changes to specifications by the quality unit, incomplete master production and control records, and non-representative sampling of active pharmaceutical ingredients. These issues indicate a lack of robust quality assurance for drug product identity, strength, quality, and purity.
ID · f89eb926-638e-4764-a121-8ef4bb77eed7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.